Financials in GBp. Standardized financial statements.
A compact view of how Trellus Health plc turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue? | £114,000 | £19,000 | £18,000 | £25,000 | £0 |
| Revenue Growth? | +500.0% | +5.6% | -28.0% | 0.0% | 0.0% |
| Cost of Revenue? | £0 | £0 | £0 | £0 | £0 |
| Gross Profit? | £114,000 | £19,000 | £18,000 | £25,000 | £0 |
| Gross Margin? | +100.0% | +100.0% | +100.0% | +100.0% | 0.0% |
| Operating Expenses? | £8.14M | £6.82M | £8.83M | £5.93M | £1.52M |
| Operating Income? | -£8.03M | -£6.80M | -£8.81M | -£5.90M | -£1.52M |
| EBITDA? | -£7.16M | -£6.50M | -£8.27M | -£5.87M | -£1.52M |
| Income Before Tax | -£7.78M | -£6.34M | -£8.81M | -£5.90M | -£1.52M |
| Income Tax Expense | £0 | £0 | £0 | £0 | £0 |
| Net Income? | -£7.78M | -£6.34M | -£8.81M | -£5.90M | -£1.52M |
| EPS? | £-0.05 | £-0.04 | £-0.05 | £-0.04 | £-0.02 |
| Diluted EPS? | £-0.05 | £-0.04 | £-0.05 | £-0.04 | £-0.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality